You are here

Arcutis Biotherapeutics

Arcutis boasts positive data for topical Phase III candidate Roflumilast

Clinical Trials Arena

Fri, 11/18/22 - 11:36 am

Arcutis Biotherapeutics

clinical trials

One down, one to go: Arcutis' repurposed AstraZeneca drug clears first PhIII eczema trial

Endpoints

Tue, 11/15/22 - 06:35 pm

Arcutis Biotherapeutics

clinical trials

With first drug on the market, Arcutis forks over $16M cash for a buyout

Endpoints

Thu, 09/8/22 - 10:56 am

Arcutis Biotherapeutics

Ducentis BioTherapeutics

With ‘bold experiment’ in drug pricing, Arcutis aims to stand out in plaque psoriasis

MedCity News

Tue, 08/2/22 - 10:38 am

Arcutis Biotherapeutics

plaque psoriasis

FDA Action Alert: Incyte, Arcutis Await Decisions in Vitiligo, Psoriasis

BioSpace

Mon, 07/18/22 - 10:22 am

Arcutis Biotherapeutics

Arcutis showcases positive PhIII data showing its topical cream scratched the sweet spot Otezla or steroids couldn't

Endpoints

Mon, 02/1/21 - 10:54 am

Arcutis Biotherapeutics

clinical trials

plaque psoriasis